IBDEI1RB ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29837,1,1,0)
 ;;=1^J0897
 ;;^UTILITY(U,$J,358.3,29837,1,3,0)
 ;;=3^Denosumab Inj 1mg
 ;;^UTILITY(U,$J,358.3,29838,0)
 ;;=J1453^^116^1483^42^^^^1
 ;;^UTILITY(U,$J,358.3,29838,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29838,1,1,0)
 ;;=1^J1453
 ;;^UTILITY(U,$J,358.3,29838,1,3,0)
 ;;=3^Fosaprepitant Inj 1mg
 ;;^UTILITY(U,$J,358.3,29839,0)
 ;;=J1710^^116^1483^46^^^^1
 ;;^UTILITY(U,$J,358.3,29839,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29839,1,1,0)
 ;;=1^J1710
 ;;^UTILITY(U,$J,358.3,29839,1,3,0)
 ;;=3^Hydrocortisone Sodium Phos Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,29840,0)
 ;;=J2150^^116^1483^58^^^^1
 ;;^UTILITY(U,$J,358.3,29840,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29840,1,1,0)
 ;;=1^J2150
 ;;^UTILITY(U,$J,358.3,29840,1,3,0)
 ;;=3^Mannitol 25% in 50 ml
 ;;^UTILITY(U,$J,358.3,29841,0)
 ;;=J2354^^116^1483^71^^^^1
 ;;^UTILITY(U,$J,358.3,29841,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29841,1,1,0)
 ;;=1^J2354
 ;;^UTILITY(U,$J,358.3,29841,1,3,0)
 ;;=3^Octreotide IV 1mg
 ;;^UTILITY(U,$J,358.3,29842,0)
 ;;=J2997^^116^1483^5^^^^1
 ;;^UTILITY(U,$J,358.3,29842,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29842,1,1,0)
 ;;=1^J2997
 ;;^UTILITY(U,$J,358.3,29842,1,3,0)
 ;;=3^Alteplase Recombinant 1mg
 ;;^UTILITY(U,$J,358.3,29843,0)
 ;;=J3262^^116^1483^86^^^^1
 ;;^UTILITY(U,$J,358.3,29843,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29843,1,1,0)
 ;;=1^J3262
 ;;^UTILITY(U,$J,358.3,29843,1,3,0)
 ;;=3^Tacilizumab Inj 1mg
 ;;^UTILITY(U,$J,358.3,29844,0)
 ;;=J9033^^116^1483^10^^^^1
 ;;^UTILITY(U,$J,358.3,29844,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29844,1,1,0)
 ;;=1^J9033
 ;;^UTILITY(U,$J,358.3,29844,1,3,0)
 ;;=3^Bendamustine HCl 1mg
 ;;^UTILITY(U,$J,358.3,29845,0)
 ;;=J9178^^116^1483^37^^^^1
 ;;^UTILITY(U,$J,358.3,29845,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29845,1,1,0)
 ;;=1^J9178
 ;;^UTILITY(U,$J,358.3,29845,1,3,0)
 ;;=3^Epirubicin HCl Inj 2mg
 ;;^UTILITY(U,$J,358.3,29846,0)
 ;;=J9305^^116^1483^78^^^^1
 ;;^UTILITY(U,$J,358.3,29846,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29846,1,1,0)
 ;;=1^J9305
 ;;^UTILITY(U,$J,358.3,29846,1,3,0)
 ;;=3^Pemetrexed Inj 10mg
 ;;^UTILITY(U,$J,358.3,29847,0)
 ;;=J2270^^116^1483^66^^^^1
 ;;^UTILITY(U,$J,358.3,29847,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29847,1,1,0)
 ;;=1^J2270
 ;;^UTILITY(U,$J,358.3,29847,1,3,0)
 ;;=3^Morphine Sulfate Inj 10mg
 ;;^UTILITY(U,$J,358.3,29848,0)
 ;;=J9267^^116^1483^74^^^^1
 ;;^UTILITY(U,$J,358.3,29848,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29848,1,1,0)
 ;;=1^J9267
 ;;^UTILITY(U,$J,358.3,29848,1,3,0)
 ;;=3^Paclitaxel Inj 1mg
 ;;^UTILITY(U,$J,358.3,29849,0)
 ;;=J2274^^116^1483^67^^^^1
 ;;^UTILITY(U,$J,358.3,29849,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29849,1,1,0)
 ;;=1^J2274
 ;;^UTILITY(U,$J,358.3,29849,1,3,0)
 ;;=3^Morphine Sulfate,Preservative-Free,Inj 10mg
 ;;^UTILITY(U,$J,358.3,29850,0)
 ;;=J9025^^116^1483^8^^^^1
 ;;^UTILITY(U,$J,358.3,29850,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29850,1,1,0)
 ;;=1^J9025
 ;;^UTILITY(U,$J,358.3,29850,1,3,0)
 ;;=3^Azacitidine Inj 1mg
 ;;^UTILITY(U,$J,358.3,29851,0)
 ;;=J9330^^116^1483^87^^^^1
 ;;^UTILITY(U,$J,358.3,29851,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29851,1,1,0)
 ;;=1^J9330
 ;;^UTILITY(U,$J,358.3,29851,1,3,0)
 ;;=3^Temsirolimus Inj 1mg
 ;;^UTILITY(U,$J,358.3,29852,0)
 ;;=J9355^^116^1483^89^^^^1
 ;;^UTILITY(U,$J,358.3,29852,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29852,1,1,0)
 ;;=1^J9355
 ;;^UTILITY(U,$J,358.3,29852,1,3,0)
 ;;=3^Trastuzumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,29853,0)
 ;;=J9299^^116^1483^69^^^^1
 ;;^UTILITY(U,$J,358.3,29853,1,0)
 ;;=^358.31IA^3^2
